Related Experiment Video
Updated: Aug 18, 2025

08:53
Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
Published on: May 16, 2017
8.8K
Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia
Chiara Fenoglio1, Maria Serpente2, Caterina Visconte3
1Department of Pathophysiology and Transplantation, Dino Ferrari Center, University of Milan, 20122 Milan, Italy.
International Journal of Molecular Sciences
|December 11, 2022
Summary
Frontotemporal dementia (FTD) shows distinct non-coding RNA (ncRNA) expression patterns. GRN and C9ORF72 mutations lead to ncRNA downregulation, while MAPT mutations cause significant ncRNA upregulation.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Frontotemporal Dementia (FTD) is a highly heritable neurodegenerative disorder.
- Genetic factors, including mutations in MAPT, GRN, and C9ORF72, are major contributors to FTD heritability.
- Pathological hallmarks of FTD include tau or TAR DNA-binding protein (TDP-43) aggregates, with emerging evidence implicating non-coding RNAs (ncRNAs) in disease mechanisms.
Purpose of the Study:
- To investigate the differential expression of ncRNAs in genetic forms of FTD.
- To explore the potential of ncRNA profiles as biomarkers distinguishing FTD subtypes.
- To understand the role of ncRNAs in the distinct pathological pathways of FTD.
Main Methods:
- An exploratory analysis was conducted using specific arrays to assess the expression levels of 84 microRNAs (miRNAs) and 84 long non-coding RNAs (lncRNAs).
- The study population included 24 genetic FTD patients (8 each with GRN, C9ORF72, and MAPT mutations), 8 sporadic FTD patients, and 8 healthy controls.
- Differential expression analysis was performed to compare ncRNA levels between patient groups and controls.
Main Results:
- A generalized downregulation of ncRNAs was observed in patients with GRN and C9ORF72 mutations compared to controls, with significant findings for several miRNAs including miR-155-5p and miR-15a-5p.
- MAPT mutation carriers exhibited a robust upregulation of several ncRNAs, notably miR-222-3p, miR-15a-5p, and miR-27a-3p.
- Distinct ncRNA dysregulation patterns were identified, suggesting a link between specific ncRNA profiles and the underlying TDP-43 or tau pathologies.
Conclusions:
- The study reveals distinct ncRNA expression patterns associated with different genetic mutations in FTD.
- These findings suggest that ncRNAs may serve as distinguishing biomarkers for FTD subtypes.
- Further validation in larger cohorts is necessary to confirm these preliminary results and their clinical implications.
Related Concept Videos
Alternative RNA Splicing
21.6K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.6K
Alzheimer's Disease: Overview
611
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
611
Neural Regulation
39.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.7K
Translation
15.1K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
15.1K

